Mapping the evolution of immune checkpoint inhibitor research in small cell lung cancer: A bibliometric analysis (1997-2025).

ABSTRACT: Immune checkpoint inhibitors (ICIs) have revolutionized small cell lung cancer (SCLC) treatment, yet a comprehensive bibliometric analysis of global research trends is lacking. This study examines publication patterns, key contributors, and emerging research focuses on ICIs in SCLC using bibliometric tools. We analyzed 809 articles from the Web of Science Core Collection (1997-2025) with VOSviewer, CiteSpace, and Bibliometrix. Publications grew at 9.11% annually, with China (304 articles), the USA (201), and Japan (101) as top contributors. Leading institutions included the University of Texas System (105 articles) and UTMD Anderson Cancer Center (84). Frontiers in Oncology (38 articles) and Thoracic Cancer (32) were prominent journals. Key researchers were Wang J (21 article

SUBMITTER: Chen Y 

PROVIDER: S-EPMC12578306 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature